In this issue of Blood, Konar and Granoff describe an elegant series of experiments that address the reason immunization against meningococcal disease can fail to protect people treated with the complement-blocking antibody, eculizumab.1
CITATION STYLE
Davies, S. M. (2017, August 17). Accept the complement (blockade). Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-07-793364
Mendeley helps you to discover research relevant for your work.